Boston Scientific Corporation (NYSE:BSX)

Angelo Anderson
January 12, 2018

The medical equipment provider reported $0.31 EPS for the quarter, hitting analysts' consensus estimates of $0.31. During last 3 month period, -0.01% of total institutional ownership has changed in the company shares. The stock increased 1.45% or $0.86 during the last trading session, reaching $60. About 13.01M shares traded or 46.57% up from the average. It has outperformed by 2.42% the S&P500. Stephens Investment Management Group Llc who had been investing in Trex Co Inc for a number of months, seems to be bullish on the $3.38B market cap company. The stock has a market cap of $32.48 billion, a price-to-earnings ratio of 450.00 and a beta of 1.09. About 2.73 million shares traded or 4.04% up from the average. Ecolab Inc. (NYSE:ECL) has risen 9.41% since January 12, 2017 and is uptrending. The legal version of this report can be read at BlackRock Inc. now owns 100,184,511 shares of the medical equipment provider's stock worth $2,777,113,000 after buying an additional 4,439,966 shares in the last quarter.

Since October 3, 2017, it had 0 insider purchases, and 1 sale for $575,000 activity. 544 shares valued at $536,666 were sold by Reynolds Shelley on Tuesday, August 15. Shares for $208,328 were sold by Sorenson John Bradley. A reading under 30 may indicate that the stock is oversold, and possibly undervalued. Its up 0.01, from 1.03 in 2017Q2. It increased, as 14 investors sold TREX shares while 63 reduced holdings. 31 funds opened positions while 73 raised stakes. Everence Inc accumulated 0.05% or 2,350 shares. After a recent check, it is observed that the insiders for the firm now own 0.10% shares. Jefferies Grp Incorporated Lc holds 3,058 shares. Insiders own 0.74% of the company's stock. (NYSE:TREX) or 285,875 shares. Budros Ruhlin And Roe stated it has 16,524 shares. Curbstone Fincl reported 0.24% stake. Dnb Asset Management As holds 29,558 shares or 0.05% of its portfolio. If investors decide to manage their own money, they may want to make sure that no stone is left unturned. Retail Bank Of Nova Scotia invested in 0.04% or 238,349 shares. Fmr owns 77,803 shares. The stock of Boston Scientific Corporation (NYSE:BSX) has "Hold" rating given on Friday, July 28 by Oppenheimer. Therefore 94% are positive. Sarepta Therapeutics had 95 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was maintained by Maxim Group on Wednesday, September 28 with "Buy". The stock of NiSource Inc. Active Investors often maintain a close study on trading capacity of ACHV stock. The firm earned "Hold" rating on Thursday, October 13 by Jefferies. The rating was maintained by Piper Jaffray with "Buy" on Tuesday, January 9. Also, SVP David A. Pierce sold 5,152 shares of the stock in a transaction dated Tuesday, January 9th. Shares for $10.11M were sold by Bose Supratim. PRIMECAP MANAGEMENT CO/CA/ also announced decreased position in Boston Scientific Corporation (BSX) during the quarter. $277,475 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Pratt Timothy A. on Friday, September 1. $1.56 million worth of stock was sold by Nanavaty Maulik on Wednesday, August 30.

Investors sentiment increased to 1.04 in 2017 Q3. Its up 0.25, from 0.94 in 2017Q2. 43 funds opened positions while 164 raised stakes. 9,373,972 shares of the company were exchanged. Wedbush downgraded the shares of SRPT in report on Thursday, April 21 to "Neutral" rating. Moreover, Tiaa Cref Invest Mngmt Limited Liability Company has 0.01% invested in Sarepta Therapeutics, Inc. Gofen & Glossberg Ltd Il reported 206,291 shares. Sg Americas Secs Limited Liability Company, a New York-based fund reported 18,868 shares. Boston Scientific Corp (Call) now has $37.33B valuation. State Common Retirement Fund holds 0.15% in Boston Scientific Corporation (NYSE:BSX) or 3.93M shares. 12,738 are held by Manatuck Hill Ptnrs. 6,702 are held by First Allied Advisory. The Manufacturers Life Insurance Company owned approximately 0.12% of Boston Scientific Corporation at the end of the most recent reporting period.

The Return on Invested Capital (aka ROIC) for Boston Scientific Corporation (NYSE:BSX) is 0.608103. 1,600 are held by Dt Invest Partners Ltd Com. The ERP5 of Boston Scientific Corporation (NYSE:BSX) is 5252. Over the same time span, the stock marked US$29.93 as its best level and the lowest price reached was US$22.94. The rating was upgraded by SunTrust on Wednesday, April 5 to "Buy". The stock has "Hold" rating by BTIG Research on Monday, June 26. The stock has "Buy" rating by Nomura on Thursday, March 17.

Several equities analysts have commented on BSX shares.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article